Jan Berkehan Erkilic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jan Berkehan Erkilic has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Alpay Karaçam
Anesthesiology, Ankara Bilkent City Hospital, Ankara 06800, Turkey
1 shared publication - Bilge Tuncer
Department of Anesthesiology and Reanimation, Bilkent City Hospital, 06800 Ankara, Turkey
1 shared publication - Burak Celik
Department of Otorhinolaryngology, Ankara Yildirim Beyazit University School of Medicine, Ankara, Turkey
1 shared publication - Cihan Doger
Anesthesiology, Ankara Bilkent City Hospital, Ankara 06800, Turkey
1 shared publication - Eda Uysal Aydın
Department of Anesthesiology, Faculty of Medicine, Bilkent City Hospital, Ankara, Türkiye
1 shared publication - Ezgi Erkılıç
Department of Anesthesiology and Reanimation, Bilkent City Hospital, 06800 Ankara, Turkey
1 shared publication
Latest Publications
- Open Access
Relationship Between Preoperative Anxiety, Salivary Cortisol, Gastric Antrum Volume, and Postoperative Emergence Delirium in Preschool Children Undergoing Adenotonsillectomy
Background and Objectives: This study examined four pre-specified relationships in 47 preschool children (aged 4–7) undergoing adenotonsillectomy: the perioperative change in salivary cortisol in relation to postoperative emergence delirium (PAED) and pain (FLACC) scores, defined a priori as the primary endpoint, and, as secondary, hypothesis-generating endpoints, the associations between preoperative anxiety (mYPAS) and salivary cortisol, between cortisol and gastric antral cross-sectional area (CSA, used as a surrogate for gastric volume), and between intraoperative anesthesia depth (PSI) and PAED scores. Materials and Methods: Preoperative anxiety was assessed using the mYPAS scale, followed by salivary cortisol sampling and ultrasonographic measurement of the gastric antral cross-sectional area (CSA, used as a surrogate for gastric volume). Postoperative recovery was monitored using PAED and FLACC scoring systems at 0, 15, and 30 min. Results: A moderately strong positive correlation was identified between mYPAS anxiety scores and preoperative salivary cortisol levels. However, no statistically significant correlation was detected between preoperative cortisol and gastric antral CSA. Furthermore, linear mixed-effects modeling did not detect a statistically significant association between the change in cortisol levels and postoperative PAED scores. Conclusions: The study confirms that preoperative behavioral anxiety in children is reflected in physiological markers like salivary cortisol. However, no statistically significant association was detected between these cortisol levels and gastric antral CSA, postoperative emergence delirium, or postoperative pain (PAED/FLACC scores) in this cohort. While mYPAS remains a valid tool for assessing preoperative anxiety, our findings do not support cortisol or gastric antral CSA as reliable predictors of post-anesthesia outcomes in this pediatric population; larger studies are needed before concluding that no such relationship exists.
Open AccessRelationship Between Preoperative Anxiety, Salivary Cortisol, Gastric Antrum Volume, and Postoperative Emergence Delirium in Preschool Children Undergoing Adenotonsillectomy
Background and Objectives: This study examined four pre-specified relationships in 47 preschool children (aged 4–7) undergoing adenotonsillectomy: the perioperative change in salivary cortisol in relation to postoperative emergence delirium (PAED) and pain (FLACC) scores, defined a priori as the primary endpoint, and, as secondary, hypothesis-generating endpoints, the associations between preoperative anxiety (mYPAS) and salivary cortisol, between cortisol and gastric antral cross-sectional area (CSA, used as a surrogate for gastric volume), and between intraoperative anesthesia depth (PSI) and PAED scores. Materials and Methods: Preoperative anxiety was assessed using the mYPAS scale, followed by salivary cortisol sampling and ultrasonographic measurement of the gastric antral cross-sectional area (CSA, used as a surrogate for gastric volume). Postoperative recovery was monitored using PAED and FLACC scoring systems at 0, 15, and 30 min. Results: A moderately strong positive correlation was identified between mYPAS anxiety scores and preoperative salivary cortisol levels. However, no statistically significant correlation was detected between preoperative cortisol and gastric antral CSA. Furthermore, linear mixed-effects modeling did not detect a statistically significant association between the change in cortisol levels and postoperative PAED scores. Conclusions: The study confirms that preoperative behavioral anxiety in children is reflected in physiological markers like salivary cortisol. However, no statistically significant association was detected between these cortisol levels and gastric antral CSA, postoperative emergence delirium, or postoperative pain (PAED/FLACC scores) in this cohort. While mYPAS remains a valid tool for assessing preoperative anxiety, our findings do not support cortisol or gastric antral CSA as reliable predictors of post-anesthesia outcomes in this pediatric population; larger studies are needed before concluding that no such relationship exists.
- 2 January 2023
- Published by SAGE Publications in Nutrition and Health
- Vol. 29 (2) , 223-229
The preventive role of vitamin D in the prevention and management of Fibromyalgia syndrome
Aim: Vitamin D deficiency is a prevalent condition among the general population, all around the world. Vitamin D deficiency is defined as serum levels of 25-hydroxy vitamin D lower than 20 ng/ml (50 nmol/ml). It is a known actor in the skeletal system through the regulation of calcium and phosphate metabolism and bone mineralization. Still, the role of vitamin D as an immunomodulator is yet to be acknowledged by healthcare practitioners as a cause, precipitating factor, and contributor to a variety of diseases. Vitamin D is shown to be an actor in multiple sclerosis, rheumatoid arthritis, insulin-dependent diabetes mellitus, and irritable bowel syndrome. Fibromyalgia syndrome (FMS) is a chronic disorder associated with a severe pain that can affect a patient's musculoskeletal system, daily routine, and mood. The clinical presentation encapsulates other disorders such as lethargy and sleep problems, brain fog and other cognitive issues, and physical and psychiatric symptoms. Methods: We have used PubMed and ResearchGate in the reviewing process of our paper. We tried to address as many topics as we judged to be adequate and relevant for the practicing clinicians. Results: Management of fibromyalgia syndrome is both nonpharmacologic and pharmacologic, which are provided in a stepwise fashion. Yet, the management of FMS remains a challenge, heeding a multidisciplinary approach. Among the dietary interventions, we chose vitamin D and its effects on FMS. Literature shows that supplementation improves pain caused by fibromyalgia syndrome, yet specific recommendations are still to be created. Conclusions: We call on all the relevant governmental bodies, public health experts and health policy makers, healthcare practitioners, and the civil society to use novel data related to fibromyalgia syndrome, and in a broader perspective, the integral role of vitamin D.
- 2 January 2023
- Published by SAGE Publications in Nutrition and Health
- Vol. 29 (2) , 223-229
The preventive role of vitamin D in the prevention and management of Fibromyalgia syndrome
Aim: Vitamin D deficiency is a prevalent condition among the general population, all around the world. Vitamin D deficiency is defined as serum levels of 25-hydroxy vitamin D lower than 20 ng/ml (50 nmol/ml). It is a known actor in the skeletal system through the regulation of calcium and phosphate metabolism and bone mineralization. Still, the role of vitamin D as an immunomodulator is yet to be acknowledged by healthcare practitioners as a cause, precipitating factor, and contributor to a variety of diseases. Vitamin D is shown to be an actor in multiple sclerosis, rheumatoid arthritis, insulin-dependent diabetes mellitus, and irritable bowel syndrome. Fibromyalgia syndrome (FMS) is a chronic disorder associated with a severe pain that can affect a patient's musculoskeletal system, daily routine, and mood. The clinical presentation encapsulates other disorders such as lethargy and sleep problems, brain fog and other cognitive issues, and physical and psychiatric symptoms. Methods: We have used PubMed and ResearchGate in the reviewing process of our paper. We tried to address as many topics as we judged to be adequate and relevant for the practicing clinicians. Results: Management of fibromyalgia syndrome is both nonpharmacologic and pharmacologic, which are provided in a stepwise fashion. Yet, the management of FMS remains a challenge, heeding a multidisciplinary approach. Among the dietary interventions, we chose vitamin D and its effects on FMS. Literature shows that supplementation improves pain caused by fibromyalgia syndrome, yet specific recommendations are still to be created. Conclusions: We call on all the relevant governmental bodies, public health experts and health policy makers, healthcare practitioners, and the civil society to use novel data related to fibromyalgia syndrome, and in a broader perspective, the integral role of vitamin D.